Anavex Life Sciences Corp. (AVXL)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| — | Q2-2026 | 8-K (2026-07-30) · 99.1 | ||
| 10-QLatest | Q1-2026 | 8-K (2026-02-09) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2025-11-25) · 99.1 | ||
| 10-Q | Q3-2025 | — | ||
| 10-Q | Q2-2025 | — | ||
| 10-Q | Q1-2025 | — | ||
| 10-K | FY-2024 | — | ||
| 10-Q | Q3-2024 | — | ||
| 10-Q | Q2-2024 | 8-K (2024-05-09) · 99.1 | ||
| 10-Q | Q1-2024 | — | ||
| 10-K | FY-2023 | — | ||
| 10-Q | Q3-2023 | — | ||
| 10-Q | Q2-2023 | — | ||
| 10-K/A | FY-2022 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Statements | ||
| Condensed Consolidated Interim Balance Sheets (unaudited) | — |
|
| Condensed Interim Consolidated Balance Sheets (unaudited) | — |
|
| Consolidated Balance Sheets | ||
| Condensed Consolidated Interim Balance Sheets (unaudited) (P) | — |
|
| Condensed Interim Consolidated Balance Sheets (unaudited) (P) | — |
|
| Consolidated Balance Sheets (P) | ||
| Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (unaudited) | — |
|
| Condensed Interim Consolidated Statements of Operations (unaudited) | — |
|
| Condensed Interim Consolidated Statements of Operations and Comprehensive Loss (unaudited) | — |
|
| Consolidated Statements of Operations and Comprehensive Loss | — |
|
| Condensed Consolidated Interim Statements of Cash Flows (unaudited) | — |
|
| Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (unaudited) (P) | — |
|
| Condensed Interim Consolidated Statements of Changes In Stockholders' Equity (unaudited) | — |
|
| Consolidated Statements of Cash Flows | — |
|
| Consolidated Statements of Operations and Comprehensive Loss (P) | — |
|
| Condensed Consolidated Interim Statements of Changes In Stockholders' Equity (unaudited) | — |
|
| Condensed Interim Consolidated Statements of Cash Flows (unaudited) | — |
|
| Consolidated Statements of Changes In Stockholders' Equity | — |
|
| Notes | ||
| Accrued Liabilities | ||
| Award Timing Disclosure | — |
|
| Basis of Presentation | — |
|
| Business Description | — |
|
| Business Description and Basis of Presentation | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Equity Offerings | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | ||
| Other Income | ||
| Pay Vs Performance Disclosure | ||
| Recovery of Erroneously Awarded Compensation | — |
|
| Segmented Information | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | — |
|